Form D · Biotechnology
Hera Biotech, Inc.
San Antonio, TX · CIK 0001831293
Offering snapshot reported Sep 23, 2026 · SEC filing
- Reported sold
- $1.74M Offering amount: $5M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 11, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$796,328 → $1,736,823
- Reported investors8 → 26
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2026 | Amendment | $1,736,823 | $940,495vs Sep 23, 2025 | 26 | SEC filing |
| Sep 23, 2025 | Initial | $796,328 | No comparison | 8 | SEC filing |
| Aug 12, 2024 | Initial | $0 | No comparison | 0 | SEC filing |
| May 31, 2023 | Initial | $260,000 | No comparison | 4 | SEC filing |
| Feb 15, 2022 | Amendment | $853,500 | $50,000vs Jan 28, 2022 | 19 | SEC filing |
| Jan 28, 2022 | Amendment | $803,500 | $708,500vs Nov 10, 2020 | 18 | SEC filing |
| Nov 10, 2020 | Initial | $95,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558408
Source: Form D, filed Sep 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Somer Baburek | Director, Executive |
| Paul Castella | Director |
| Wendy Smith | Director |
| Teo Tijerina | Director |
| Neal Walsdorf, Jr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:San Antonio, TX, 78249
Phone: 2106831069